… [ 105 ] Herein, platinum nanoparticles acted as catalase mimics, while gold nanoparticles
with an ultrasmall size worked for GO X mimics. Supported porphyrin framework played roles …

… Schematic model of signaling pathways implicated in tumor cell vascular mimicry (VM). … a
protein and/or downstream effector protein or proteins in modulating VM in aggressive cancer …

… mimics) are small organic molecules bearing an identifiable resemblance to peptides or
peptide segments of proteins. … to interact with the same target protein of interest by arranging …

… and sheets at protein–protein interfaces, application of β-strand or β-sheet mimics as
modulators of PPI is limited. Strand designs are challenging because mimics with appropriately …

… and tertiary protein domain mimics (PDMs) to specifically modulate PPIs. … mimics described
in this paper. He is also cofounder of Inthera Bioscience, which is pursuing therapeutic …

… Our strategy for the design of such agents involves the mimicry of side-chain residues on
one face of the α-helix; these residues frequently play a key role in mediating protein–protein …

Vasculogenic mimicry (VM) describes the process utilized by highly aggressive cancer cells
to generate vascular-like structures without the presence of endothelial cells. VM has been …

… state represents “mimicry” by cancer cells that leads to phenotypic plasticity. CSC mimicry
is … , or lymphangiogenic cells to support cancer growth. CSCs facilitate both paracrine and …

… unrelated epitope from the Titin protein presented on cardiac tissue… mimicry leading to
clinically relevant fatal toxicity, mediated by a modified enhanced affinity TCR designed for cancer …

… of proteins that recognize a wide range of targets in therapeutic, diagnostic and research-based
applications. During the past decade, the number of antibodies approved for clinical use …